Day: February 10, 2022

Publication demonstrates FDA cleared Acuitas AMR Gene Panel detects and differentiates a broad range of 28 AMR markers that can be associated with up to 9 antimicrobial classesProvides results at least a day earlier than traditional methods to guide patient management and support antibiotic stewardship and infection control programsAssociating the Acuitas AMR Gene Panel markers with “not susceptible” results from culture is a key differentiatorROCKVILLE, Md., Feb. 10, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today the release of a new peer-reviewed journal publication that demonstrates that the Acuitas® AMR Gene Panel accurately detects and differentiates 28 genetic...

SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2021 financial results on Thursday, February 24, 2022 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. Conference Call InformationDate:   Thursday, February 24, 2022Time:   4:30 p.m. ETDial-in numbers:   +1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)Confirmation code:   6217409Live webcast:   Travere.com in the “Events & Presentations” section of the “Investors” pageA replay of the call will be available from 7:30 p.m. ET, February 24, 2022 to 7:30 p.m. ET, March 3, 2022. The replay number is +1 (855) 859-2056 (U.S.)...

BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laurence Reid, Ph.D., Chief Executive Officer of Decibel, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 3:00 p.m. ET. A live webcast of the fireside chat may be accessed by visiting the Investors section of the Decibel Therapeutics website at https://ir.decibeltx.com. An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the fireside chat. About Decibel Therapeutics Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering...

Yoti digital identity services to be offered via the First Advantage technology platformJoint go-to-market strategy enables promotion of digital identity services aligned with upcoming April 2022 updates to UK Right to Work & UK DBS ChecksATLANTA and LONDON, Feb. 10, 2022 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading global provider of technology solutions for screening, verifications, safety and compliance related to human capital, has announced the signing of a strategic technology integration partnership with Yoti, a U.K.-based digital identity leader. The technology integration partnership will allow First Advantage to offer Yoti digital identity services directly through the First Advantage technology platform. This partnership arrives ahead of planned changes to the UK Right to Work &...

TORONTO, Feb. 10, 2022 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2021 financial results after market close on Thursday, March 3, 2022. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2021 Results Conference Call Details:Date: Thursday, March 3, 2022   Time: 4:30 p.m. ET   Live Call: 1-833-710-1825 (Canada and the United States)  1-929-517-0404 (International)   Replay: 1-404-537-3406   Conference ID: 9608479   The call will also...

WESTPORT, Conn., Feb. 10, 2022 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that it plans to release financial results for the fourth quarter ended December 31, 2021, on Thursday, February 24, 2022, after the close of market trading. The Company has scheduled a conference call to discuss the results on Thursday, February, 24 2022 at 5:00 p.m. ET. The conference call will feature remarks by Elias J. Sabo, Chief Executive Officer, Ryan J. Faulkingham, Chief Financial Officer, and Pat Maciariello, Partner and Chief Operating Officer of CGM. To participate in the call, please dial (844) 200-6205 (domestic) or + 1 929 526 1599 (international). The passcode is 091769. Please dial into the call at least five minutes before the scheduled start...

FREMONT, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) — ACM Research, Inc. (NASDAQ: ACMR) announced today that it will release its financial results for the fourth quarter and fiscal year 2021 after the U.S. market close on Thursday, February 24, 2022. The company will conduct a conference call on Friday, February 25, 2022, at 8:00 a.m. U.S. Eastern Time (9:00 p.m. China Time) to discuss the results.What: ACM Research Fourth Quarter and Fiscal Year (ended December 31, 2021) Earnings CallWhen: 8:00 a.m. U.S. Eastern Time on Friday, February 25, 2022Webcast: ir.acmrcsh.com/eventsPlease dial in 10 minutes before the call is scheduled to begin and provide the passcode 9396606 to join the call.  Phone Number Toll-Free NumberUnited States +1 (661) 567-1217 +1 (833) 562-0137Hong Kong +852 58194851 +852 800966253Mainland...

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a U.S.-based Bitcoin mining company, today announced it will provide a business update and release its fourth quarter 2021 financial results before U.S. markets open on Friday, March 4, 2022. Cipher will host a conference call and webcast that day at 8:00 a.m. Eastern Time. The live webcast and a webcast replay of the conference call can be accessed from the investor relations page of Cipher’s website at https://investors.ciphermining.com. To access this conference call by telephone, dial (844) 689-1757 or (929) 517-0940 and use the conference ID 2281989. About CipherCipher is an industrial-scale Bitcoin mining company dedicated to expanding and strengthening the Bitcoin network’s critical infrastructure. Its goal is...

STOUGHTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that the Company will host a conference call and live audio webcast on Thursday, February 24, 2022, at 4:30 p.m. Eastern Time. The Company will discuss its fourth quarter and full-year 2021 financial results and provide a corporate update. Conference Call Information  The Company will host a conference call and live audio webcast on Thursday, February 24, 2022, at 4:30 p.m. Eastern Time. To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Q4 2021 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately...